Groups: (Hardly‽) overlapping CIs [Design Issues]

posted by BEQool  – 2024-11-22 13:32 (139 d 10:16 ago) – Posting: # 24291
Views: 2,281

Hello Helmut,

thank you for the example provided. Unfortunately, these kind of deficiency questions will probably become inevitable when conducting a study in groups.

❝ […] a separate exploratory analysis of each group was performed and produced the following outcomes

Did you perform this exploratory analysis of each group or did the agency do it?

❝ Therefore, the applicant should provide a justification for this difference and discuss its potential impact on the conclusion of bioequivalence.

❝ A new term: Hardly overlapping CIs. Again: So what? Justification?

How do you plan to "justify" this difference?

Regards
BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,422 posts in 4,927 threads, 1,671 registered users;
28 visitors (0 registered, 28 guests [including 12 identified bots]).
Forum time: 00:49 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5